for gene therapies
ABOUT OUR PROJECT
ContiVir is a research project of the Max Planck Institute with the vision of operating a unified platform technology for virus production & purification that can produce viral vectors to gene therapy standards at tenfold efficiency compared to today
We are developing a highly efficient virus production system based on a continuous tubular bioreactor & a capture chromatography step with virtually full recovery for a wide range of viruses.
These technologies together can be up to ten-fold more efficient than current production platforms.
Video of ContiVir technology:
COMPARED TO BATCH VIRUS PRODUCTION
(20 times smaller equipments)
(save weeks or months)
(reduced manufacturing costs)